Qlife announced on 22 April that a research agreement had been made with Nordsjällands Hospital (NOH), for continued validation of the COVID-19 test.
Corona virus, COVID-19, has limited impact on Qlife Holding AB
Qlife went public on March 2 with a clear strategy for the next year, that strategy is still being followed and we do not see any large obstacles to it due to the Corona virus outbreak. The interest for our Egoo Home System has not waned. On the contrary, the interest in being able to test patients at home compared to at a hospital is increasingly attractive in a time where limitation of infection is in focus. This is a focus that will have even more attention in the future when our health sector needs to be prepared if or when a similar situation evolves.
This increasing interest makes up for the short-term effects of the corona virus where Qlife are following the guidelines of the Danish government to limit the spread and to protect their employees from infection. All non-essential international travels have been cancelled and all employees, for whom its possible, are from today, March 13th working from home.
“We believe that the potential for the Egoo Home System is increasing in the long run, and we prepare ourselves for deliveries to a healthcare system that will have been under a lot of pressure and will need all the technological aid they can to bounce back stronger than before” Thomas Warthoe, CEO
Resolution on adoption of accounts and allocation of the company’s result
FINANCIAL SUMMARY FIRST QUARTER 2020
The parties have agreed a testing plan for all players, judges and club staff for Covid-19 in the professional leagues (3F SuperLiga and NordicBet Liga).
Qlife announces that it has entered into a research agreement with Nordsjællands Hospital (NOH), to continue the validation of the Egoo Sars-CoV-2 virus test.
Information regarding the coronavirus
Due to increased requests for information on route to market for Qlife’s COVID-19 test the company is updating the following:
Qlife announces that it has closed a license and supply agreement with Aidian Oy to access and incorporate their patented SIBA® Technology into the Egoo.Health platform.
Qlife went public on March 2 with a clear strategy for the next year, that strategy is still being followed and we do not see any large obstacles to it due to the Corona virus outbreak.